News
Pharmaceutical Technology on MSN14h
AGC Biologics and Quell to progress Treg cell therapy developmentThe Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback